Inside PIC/S - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
Inside PIC/S

Inside PIC/S: Top GMP Deficiencies

April 2, 2012
By: Hans Smallenbroek, Boon Meow Hoe
Pharmaceutical Technology

Comparison of the top GMP deficiencies cited by the PIC/S Participating Authorities.

Inside PIC/S: The Importance of PIC/S in a Globalized World

October 2, 2011
By: Tor Graberg
Pharmaceutical Technology

Expanding the organization's mandate will strengthen inspections.

FDA Obtains Sought-After PIC/S Membership

February 2, 2011
By: Joey Gouws
Pharmaceutical Technology

Nearly six years after applying, the FDA joins the Pharma Inspection Co-operation Scheme.

Inside PIC/S: Implementing Quality Risk Management

December 2, 2009
By: Lionel Viornery, Philippe Legoff
Pharmaceutical Technology

Representatives to the PIC/S provide an example of methodology for implementing ICH Q9.

Inside PIC/S: South Africa's Accession to PIC/S

August 2, 2009
By: Joey Gouws
Pharmaceutical Technology

South Africa was the first country on the African continent to become a PIC/S member. The country's Director of Inspectorate and Law Enforcement describes the 10-year process.

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
100%
Facility/environment problems
0%
Process development problems
0%
Production equipment downtime
0%
Raw material supply problems
0%
Regulatory restrictions
0%
Business decisions to limit production
0%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Click here